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~ A New Percutaneous Vascular Surgical Devlce 
After PTCA and 8tenting 
Winfded Haerer, Ralph 8chulze, Bernd Ludwig. Dr Haemr Hospital, U/m, 
Germany 
The femoral artery is the most common vessel access for inte~ventional 
pmceduras. Local problems am frequent by using larger devices or strong 
anticoa0ulation protocols after stenting. Therefore we used the new single 
c~gerator percutaueous vascular surg.~al device (Perdoss) in a prospective 
•al. The new 9 F-dovlee has a sheath which houses four sutured needles. 
The knom are made outside and are advanced by a special knot pusher to 
the arlenJ surface. 
A consecutive uehes of 350 patients (pts) was included. PTCA, atheree- 
tomy or stont deployment was done by use of 8 or 9 F guiding catheters. A 
successful stont implantation was carded out in 320 pts of this series. In these 
cases the surgical dolce was employed immediato,~y after the Intetventional 
procedure and them was no need for a withdrawal of hepadn. The patients 
had to stay in bed for only 4 hours with a mild compression bandage and 
were aliowed to walk after this period. 
The results were as follows: Procedural success 322/3~ pls (92%), false 
anemysm 0/322 pts, haemota (over 5 cm) 0/322 pts, vees~; !hmmhosts 0/322 
pts. Compression of the artery (up to 1 hour) was done in Ihe remaining 38 
pts followed by a light compression bandage (1 aneuWsm). Before use of 
the ne#v device our local complications were 1% false a~eurysm or bleeding 
with surgical repair and 8% severe heematoma. 
The new percutaneous vascular surgical device reduces local complice- 
tlona. AnScoagula~on protocols can be administered unchanged and there- 
fore the results of complex angioplasty can be optimized. 
~ T h e " D a r k  Overly Aggressive Side" of Muk'ldevice 
Athemctomy 
Gaston R. Dussaillant, Gary S. Mintz, Augusto O. Ploha~, Kenno~ 
M. Kent, lowell F. Satier, Jeffrey J. Popma, Theresa Bucher, Carol Walsh, 
Paul Mackel, Regina Deible, Bridget Golden, Martin B. Leon. Washington 
Hospital Center, Washington, DC 
Adjunctive DCA follewh~g mlationa} atherectomy (RA) results in a larger fu- 
men than stand-alone RA or RA+ad]uective PTCA. To assess the iongterm 
Mects of this strategy, we folkn~ed 183 pts treated wi~ RA+ad~mc~e DCA 
and imaged using intravascular ullraseund. Pra- and post - imer~n a~te- 
dal, lumen, and plaque areas (mn~ were used to calculate plaque humeri 
(plaque/mleflal reas) and the contribution of tissue removal to lumen en- 
largement (atheractomy index = Aplaque/Alumen areas). After 11.8 4- 4.5 
mos, 38 pts (23%) required ta,'gof lesion revascularization (TLR): 
No TLR "R.R p 
Pm-intenmntlon artedat area 18.1 ±5.3 18.74-4.3 0.669 
I.umen area 1.9~ 1.0 1.7d:0.8 0.522 
Plaque area 16.24-5.1 17.04-4.4 0.491 
Post~t lon  artedal area 20.7 4. 5.9 19.6 4. 5.1 0.377 
~ama 6.8:1:2.1 8.04-18 0.049 
Plaque 8ma 13.84-4.9 13.74-4.8 0.g02 
Raque bumen (%) 664.8.7 694- 0.0 0.103 
~ Imbx (%) 88±25 844-~ o.e¢~ 
Reference lumen area and total and supedlclal arcs of lesion calcium 
were similar. Nthough post-intervention lumens were sllghtty Sheller (6.0 
vs 6.8 mm~), the atherec~omy irWex was gdkingly greater (84 vs 59%) in 
10is requiring TLR. We conc/ude that the strategy of RA+DCA results in 
favorable Iongterm pt outcomes (TLR = 23%). However, pts requiring TLR 
had more aggressive tissue removal (higher atherecfomy Index) suggesting 
t~t  exaggerated eep vessel wall injury may be do~edous. 
~ Reduced Antlcoagulstion Stesting Protocol for 
(RAPS) in Smaller Coronary Vessels Using 
fntravascuiar UIb'asound Guidance. 30 Day 
~ura l  Results 
David K. Roberts, AnM Arthur, Raye L Bellinger, James E. Lewis, Shenjl 
I. Haas, Carol A. Pariss. Sulter Instilute for Medical Research, and U.C, 
Oa',#s Affiliated Hospitals, Sacramento, CA 
Although coronary stenting (S) of smaller < 3 mm vessels (SCV) was initially 
fdonlffled as a risk racer for stent lhmmbosis, STRESS enrolled a signlflcout 
number of SCV with acceptable results. We report he initial 30 day results 
Of RAPS in SCV. 43 patients with 57 lesions in 2.5-,3.0 nun native coro- 
nary vessels underwent stentle9 using 79 Palmaz-Schetz coronmy stem. 
Lesion indications were 51 (89.5%) de novo P._-x~ive, 1 (1.8%) restenottc, 
and 5 (8.7%) suboptimal results or threatened closures following balloon 
angioplasly or athe~¢tomy. Clinical [mese~a~on was 23 (53.4%) unstable 
angina, 14 (32.6%) stabla angina, and £ (14.0%) < 72 hours 8/P MI. Follow- 
ing intravascular ultrasound (WUS), final stent deployment was performed at 
16.08 =I: 0.62 atmospheres. All stonts had a lloal cross-seclional area (CSA) 
>_ 80% of reference vessel CSA, and wee treated with aspidn 325 mg and 
tk~ina  '300 mg daily for one month, and enoxapadn 60 mg daily for three 
weeks. IVUS Results 
Reference vessel (:S'A mm 6.65 ± 0.31 
Refemnoe Vessel MLD mm 2.5 :b 0.07 
Vessel MaJofR~mor Axis Ratio 0.78 ± 0.02 
Reference Stent CSA mm 7.56:1:0.40 
Reference ~ent MID mm 2.71 =t: 0.09 
Stent Minor/Maim Axis 0.80 ± 0.02 
Mean % CSA b"t'erd ~enods -13.7 4. 0.04% 
Mean % MI.D Stent S1enosis --8.4 + 0.03% 
There were no RAPSprocedural complica~ons ofdeath, MI, or emergency 
CABG. Thee were no s ign~ bleeding ¢omplicaliona requiting blood 
b-ansfusion. 1 patient developed a femoral pseudoaneurysm that resolved 
with compression. There were no stent acute ~'~ subacute th in - - i s .  
In condus/on: Coronary stent~ng Of smaller vessels with intmvascolm, u~'a- 
sound guidance for high pressure gent deployment can be pedormed safely 
with excellent one month procedural resufls usin~ a reduced anticoagulation 
regimen. 
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~"~- '~ foh ib~ of  Imlucibfe Nitric Oxide Synlhase 
Reduces Myocardial Injury in Autolmmune 
Myocardms Ram 
Michiaki Hiroe, Shiperu Ishlyama, Toshio Nlsh~awa, Hime Nakazawa, 
Hireshi Ito, Takashi Shimojo, Takeshi Kasajima, Fumiaki Marureo. Tokyo 
Medical and Dental Univemity, Tokyo Women~ Medical Co#eoe, Tokai 
Un~s~,  Japan 
We have previously demonstrated the expression of inducible Nlaic Oxide 
Syuthese (~OS) and perexyn~e in impaired myocam~ c~ ~ong with 
increased nitrite f o ~  and 02- radical pnxJt¢~n in autoimmune my- 
ocerd~s rets, suggesting that NO modu~tes myocard~J (bmago h~ this my- 
ocamle;, in the prasent study, we investigated ~ aminogttanidine(AG), 
a selec~ve inhibitor of iNOS, modulates the inflammatory oSsorder of my- 
ocarcli'ds. Lewis rats were sens~ to develop myocarditts with an injection 
of porcine myosin. AG (400 mg/kg per day) was intraperitoneally admin- 
istered to ~s  every ~ay from the day pdor to the flint immunization with 
myosin. Hearts v,em removed for examkzalJon on day 21. Blood samples 
were simultaneously taken from the heart cavity. The severity of myocarcli- 
tls was assessed by measudng the h~11x)fogic~ly alfected % area and 
serem CIr. MB le~ele. Serum NOx levels were alse meastm~l, l~an % area 
of ioflansn~tow lesions and CK-MB levela were s ign i f i~  decreased in 
the rats with ~ given AG. 
NOxlmM) CK-Malngtrn~) Area('/,} 
Myosin conlml (n - 10) 784-12 1024-16 .r,R ~ 13 
"P < 0,01,"P < 0.0(]1 
Conclusions: AG Inh~dds the extension Of n ' ~  InJt.w in ;'n',;ocaxo~is 
by s~l:.~-~lg NO overpreducl~n. AG may be an effective drug for the 
Ueatment of myocami,s. 
• '"  Cell Infiltration tn the Subacute Phase ow 
Myocerdms 
Yasushl Abe, Jiy~ng Klm, Masatake Fukunaml, Masaham Ohmork 
Tsuyeshi Shimonagata, Kazuaki Kumagak Takahisa Yan~da, Motoo Dat., 
Syo~ Sanada, Nodtske Hofd. D/vfs/on of ~ .  Osaka Prafeofur'~ 
Hes~ta/, Os,~,~ Japan 
The leflammatory cell infillz-ation i  the subacute phase of acute mycoan~is 
might detsdorate the recovery of left venlficol~LV) function through factors 
such as c '~ .  To elucidate whether myo~t  inflammatory cells in- 
lIIIralion in the subacute phase Of myocaldltis i rd l~  the Ixognosis of 
loft ventdcolar funotion, we sfudiod 16 pts with acoto ~ ~ 
dmk~.  Endomyeeard~ biopsy spedmens(3-4 plasas) were taken ~om 
